Submitted by admin on September 29, 2022 - 10:31am
Medicare Part B premiums to drop 3% next year, partly due to limited Aduhelm coverage
Ventus sells its lead drug candidate to Novo Nordisk
Biohaven's ALS drug fails to meet study goals
CVS in another bidding war
*please scroll down for all the latest news*
